home / stock / etnb / etnb news

ETNB News and Press, 89bio Inc. From 03/23/23

Stock Information
Company Name: 89bio Inc.
Stock Symbol: ETNB
Market: NYSE
Website: 89bio.com
Menu
ETNB ETNB Quote ETNB Short ETNB News ETNB Articles ETNB Message Board
Get ETNB Alerts

News, Short Squeeze, Breakout and More Instantly...
ETNB - KA, VIA and ETNB among mid-day movers

2023-03-23 12:47:58 ET Gainers: DiamondHead Holdings ( DHHCU ) +111% . DiamondHead Holdings ( DHHC ) +91% . Boxed BOXD +88% . ZyVersa Therapeutics ZVSA +33% . Amprius Technologies ( AMPX ) +30% . Kineta ( KA ) +29% . ...
ETNB - WKHS, OPEN and BILI are among pre market gainers

2023-03-23 09:00:16 ET Advent Technologies Holdings ( ADN ) +34% enter into joint development pact. ZyVersa Therapeutics ( ZVSA ) +26% . BioSig Technologies ( BSGM ) +17% . Aziyo Biologics ( AZYO ) +14% Q4 Earnings call release Generatio...

ETNB - 89bio proposes $200M stock and warrants offering

2023-03-22 16:33:56 ET 89bio ( ETNB ) said Wednesday it commenced an underwritten public offering of $200 million of shares of its common stock, and pre-funded warrants to purchase its common stock. 89bio is expected to grant the underwriters of the offering an option for a period...

ETNB - 89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

SAN FRANCISCO, March 22, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that ...
ETNB - LKCO, VIA and ADD among mid-day movers

2023-03-22 13:29:15 ET Gainers: GameStop ( GME ) +41% . Telesis Bio ( TBIO ) +31% . EZGO Technologies ( EZGO ) +33% . CorEnergy Infrastructure ( CORR ) +28% . 89bio ( ETNB ) +25% . JanOne ( JAN ) +27% . InMed Phar...

ETNB - 89bio, SCYNEXIS top healthcare gainers; NuCana, Nutex among losers

2023-03-22 10:02:09 ET Gainers: 89bio ( ETNB ) +38% . SCYNEXIS ( SCYX ) +21% . Athersys ( ATHX ) +20% .  Sol-Gel Technologies ( SLGL ) +19% . LifeMD ( LFMD ) +11% . Losers: NuCana ( NCNA ) -10% . Nutex Hea...

ETNB - AMC, SCYX and CDTX among pre market gainers

2023-03-22 08:21:40 ET 89bio ( ETNB ) +50% on topline data for NASH candidate. GameStop ( GME ) +48% on Q4 earnings. Telesis Bio ( TBIO ) +17% on Q4 earnings. Pyxis Oncology ( PYXS ) +11% on Q4 earnings. Ollie's Bargain O...
ETNB - 89bio gains 47% on topline data for NASH candidate

2023-03-22 07:44:35 ET Liver disease drug developer 89bio ( NASDAQ: ETNB ) added ~47% on Wednesday after announcing topline data from its Phase 2b ENLIVEN trial for pegozafermin in patients with nonalcoholic steatohepatitis (NASH). The trial involved 219 patients who wer...

ETNB - 89bio's Phase 2b ENLIVEN Trial of Pegozafermin in Nonalcoholic Steatohepatitis (NASH) Achieved High Statistical Significance on Both Primary Histology Endpoints with Weekly (QW) and Every-Two-Week (Q2W) Dosing at 24 Weeks

- 44mg Q2W dose had a placebo-adjusted effect size of 20% on at least one-stage fibrosis improvement without worsening of NASH (p=0.008) and 24% on NASH resolution without worsening of fibrosis (p=0.0005) - - 30mg QW dose had a placebo-adjusted effect size of 19% on at least one-stage f...

ETNB - 89Bio: A Promising NASH Innovator

2023-03-17 18:18:37 ET Summary As pegozafermin has a differentiated mode of action from Madrigal's resmetirom, 89bio, Inc. can offer an intriguing solution for NASH. Early pegozafermin data showed extremely strong liver fat reduction as well as improvement in NASH. The upcomin...
Previous 10 Next 10